Today: 9 June 2026
Browse Category

TSX:NA.TO 3 December 2025 - 22 February 2026

TSX Week Ahead: Toronto Stock Exchange record close faces bank earnings rush and Canada GDP test

TSX Week Ahead: Toronto Stock Exchange record close faces bank earnings rush and Canada GDP test

The S&P/TSX Composite closed at a record 33,817.51 on Friday, up 0.7% after a U.S. Supreme Court ruling against Trump’s tariffs boosted financials and miners. Canadian bank earnings begin Tuesday, with key GDP and current account data due later in the week. The Canadian dollar slipped 0.5% to 1.3687 per U.S. dollar. U.S. tariff policy and oil prices remain key market drivers.
National Bank of Canada Stock (NA.TO) Near Record Highs After Q4 2025 Earnings Beat and Dividend Hike

National Bank of Canada Stock (NA.TO) Near Record Highs After Q4 2025 Earnings Beat and Dividend Hike

National Bank of Canada shares closed at C$170.90 on December 3, just below record highs, after reporting Q4 adjusted profit of C$1.16 billion, up from C$928 million a year earlier. The bank raised its quarterly dividend by 6 cents to C$1.24. Shares have surged nearly 30% in 2025, trading at a premium to historical valuations. Most analysts rate the stock Buy or Hold, but average price targets sit below current levels.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Go toTop